Hyderabad: Aurigene Pharma to set up USD 40M facility at Genome Valley

Hyderabad: Aurigene Pharmaceuticals Services, a unit of Dr. Reddy’s laboratories, will invest 40 million dollars to open a biomanufacturing facility at the city’s Genome Valley.

Telangana IT and Industries Minister KT Rama Rao took to twitter to announce Aurigene’s facility, which is set to provide employment to around 250 people.

Genome Valley is India’s first organized cluster for Life Sciences research and development, and clean manufacturing activities. It is home to 200 companies with a workforce of about 15,000 employees.